Search Results
Treatment for High- and Low-Risk HER2+ Breast Cancer
Treating Low-Risk HER2-Positive Breast Cancer
Adjuvant Therapy for High-Risk HER2+ Breast Cancer
Early breast cancer: do we need chemotherapy in low genomic/high clinical risk (ER+/HER2-)?
Treatment Updated for HER2 Positive Breast Cancer: Changing Paradigms
Update from KAITLIN for high-risk HER2-positive early breast cancer
Adjuvant treatment for stage I HER2+ breast cancer
Optimizing Therapy in HER2+ Disease with Dr. Hope S. Rugo
Moving the Needle in ER-Positive/HER2-Negative Metastatic Breast Cancer: Exploring SERD Strategies
HER2DX risk-score in early-stage HER2-positive breast cancer
Neoadjuvant Therapy for HER2-positive Breast Cancer - Dr. Scott Christensen
Important considerations in the management of HR+, HER2-negative early breast cancer
